These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26272554)

  • 21. Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs.
    Dutta A; Huang CT; Lin CY; Chen TC; Lin YC; Chang CS; He YC
    Sci Rep; 2016 Sep; 6():32973. PubMed ID: 27596047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD47 Plays a Role as a Negative Regulator in Inducing Protective Immune Responses to Vaccination against Influenza Virus.
    Lee YT; Ko EJ; Lee Y; Lee YN; Bian Z; Liu Y; Kang SM
    J Virol; 2016 Aug; 90(15):6746-6758. PubMed ID: 27194758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for phagocytosis of influenza virus-infected, apoptotic cells by neutrophils and macrophages in mice.
    Hashimoto Y; Moki T; Takizawa T; Shiratsuchi A; Nakanishi Y
    J Immunol; 2007 Feb; 178(4):2448-57. PubMed ID: 17277152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Superiority of IFN-λ as a Therapeutic Candidate to Control Acute Influenza Viral Lung Infection.
    Kim S; Kim MJ; Kim CH; Kang JW; Shin HK; Kim DY; Won TB; Han DH; Rhee CS; Yoon JH; Kim HJ
    Am J Respir Cell Mol Biol; 2017 Feb; 56(2):202-212. PubMed ID: 27632156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus.
    Zhao J; Zhu M; Jiang H; Shen S; Su X; Shi Y
    Sci Rep; 2019 Mar; 9(1):5272. PubMed ID: 30918324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose supplementation with active hexose correlated compound improves the immune response to acute influenza infection in C57BL/6 mice.
    Nogusa S; Gerbino J; Ritz BW
    Nutr Res; 2009 Feb; 29(2):139-43. PubMed ID: 19285605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective effects of intranasal administration of IL-12 given before influenza virus infection and the negative effects of IL-12 treatment given after viral infection.
    Ishikawa H; Ino S; Sasaki H; Fukui T; Kohda C; Tanaka K
    J Med Virol; 2016 Sep; 88(9):1487-96. PubMed ID: 26864280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection.
    Pugh ND; Edwall D; Lindmark L; Kousoulas KG; Iyer AV; Haron MH; Pasco DS
    Phytomedicine; 2015 Feb; 22(2):271-6. PubMed ID: 25765832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel intranasal virus-like particle (VLP) vaccine designed to protect against the pandemic 1918 influenza A virus (H1N1).
    Matassov D; Cupo A; Galarza JM
    Viral Immunol; 2007 Sep; 20(3):441-52. PubMed ID: 17931114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of the Microparticle Nanoscale Silicon Dioxide as an Adjuvant To Boost Vaccine Immune Responses against Influenza Virus in Neonatal Mice.
    Russell RF; McDonald JU; Lambert L; Tregoning JS
    J Virol; 2016 May; 90(9):4735-4744. PubMed ID: 26912628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influenza and dengue virus co-infection impairs monocyte recruitment to the lung, increases dengue virus titers, and exacerbates pneumonia.
    Schmid MA; González KN; Shah S; Peña J; Mack M; Talarico LB; Polack FP; Harris E
    Eur J Immunol; 2017 Mar; 47(3):527-539. PubMed ID: 27995614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ribavirin attenuates the respiratory immune responses to influenza viral infection in mice.
    Liao SH; Li Y; Lai YN; Liu N; Zhang FX; Xu PP
    Arch Virol; 2017 Jun; 162(6):1661-1669. PubMed ID: 28243801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate and broad-spectrum protection against heterologous and heterotypic lethal challenge in mice by live influenza vaccine.
    Seo SU; Lee KH; Byun YH; Kweon MN; Seong BL
    Vaccine; 2007 Nov; 25(47):8067-76. PubMed ID: 17919786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2-Mediated Impairment of Innate Immune Response to A(H1N1)pdm09 Infection in Diet-Induced Obese Mice Could Be Restored by Paracetamol.
    Zhang AJX; Zhu H; Chen Y; Li C; Li C; Chu H; Gozali L; Lee ACY; To KKW; Hung IFN; Yuen KY
    J Infect Dis; 2019 Feb; 219(5):795-807. PubMed ID: 30202973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocyte-derived dendritic cells enhance protection against secondary influenza challenge by controlling the switch in CD8
    Cruz JL; Pérez-Girón JV; Lüdtke A; Gómez-Medina S; Ruibal P; Idoyaga J; Muñoz-Fontela C
    Eur J Immunol; 2017 Feb; 47(2):345-352. PubMed ID: 27859043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.
    Kreijtz JH; Bodewes R; van Amerongen G; Kuiken T; Fouchier RA; Osterhaus AD; Rimmelzwaan GF
    Vaccine; 2007 Jan; 25(4):612-20. PubMed ID: 17005299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Fang F; Zheng M; Chen Z
    Vaccine; 2010 Nov; 28(48):7690-8. PubMed ID: 20870054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exposure to combustion generated environmentally persistent free radicals enhances severity of influenza virus infection.
    Lee GI; Saravia J; You D; Shrestha B; Jaligama S; Hebert VY; Dugas TR; Cormier SA
    Part Fibre Toxicol; 2014 Oct; 11():57. PubMed ID: 25358535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.